SCHEMBL787455

SCHEMBL787455

O=C1[N]C=CN1c1ccc(-c2nnc(Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)c3ccccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 2/20 0.50
MAPT P10636 4/20 0.46
LMNA P02545 1/20 0.45
KDR P35968 10/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE5A O76074 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP2C19 P33261 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE1C Q14123 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL793282 0.81 CA9 (0.49) CA9MAPTLMNAKDRGAA
SCHEMBL793667 0.80 CA9 (0.48) CA9MAPTLMNAKDRGAA
SCHEMBL787798 0.79 CA9 (0.48) CA9MAPTLMNAKDRGAA
SCHEMBL788084 0.79 CA9 (0.48) CA9MAPTLMNAKDRGAA
SCHEMBL787650 0.78 CA9 (0.55) CA9MAPTLMNAKDRGAA
SCHEMBL787904 0.78 KDR (0.57) CA9KDRGAANPSR1ALDH1A1
SCHEMBL787771 0.77 MAPT (0.58) CA9MAPTKDRGAANPSR1
SCHEMBL787744 0.77 KDR (0.70) CA9KDRALDH1A1POLBBRAF
SCHEMBL787820 0.75 KDR (0.72) CA9MAPTKDRALDH1A1SMN1; SMN2
SCHEMBL787384 0.75 KDR (0.67) CA9MAPTKDRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616443-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS Exelixis, Inc. (US) 2013-07-24 EP claimed
WO-2012037132-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS EXELIXIS, INC. (US) 2012-03-22 WO claimed